Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > Arrowhead Subsidiary Unidym, Inc. Acquired by Wisepower Co., Ltd. for up to $140 million earn-out plus $5 million upfront

rrowhead Research Corporation (NASDAQ: ARWR) today announced that its Unidym, Inc. subsidiary has been acquired by Wisepower Co., Ltd., a publicly-traded, Seoul, Korea-based electronics company (KOSDAQ: 040670).

Arrowhead Subsidiary Unidym, Inc. Acquired by Wisepower Co., Ltd. for up to $140 million earn-out plus $5 million upfront

Pasadena, CA | Posted on January 19th, 2011

Upfront consideration to Unidym shareholders consists of Wisepower stock and convertible bonds valued at US $5,000,000 with certain restrictions as to timing of stock sales. Unidym shareholders are also entitled to cash earn-out payments up to US $140 million based on cumulative sales and licensing milestones. Finally, Unidym shareholders will receive 40% of licensing revenue from a set of patents that have been generating increasing quarterly royalties in addition to the potential $140 million earn-out. The transaction enables Arrowhead to substantially decrease its burn rate, focus exclusively on nanomedicine, and retain significant upside exposure as Unidym penetrates its target markets with the help of an experienced partner in Wisepower.

Wisepower is a leading supplier of Li-polymer batteries for mobile appliances in Asia, and its current customers include cellular phone manufacturers such as LG Electronics, Pantech, and KTFT. Wisepower has recently developed high quality LED packages and solid-state lighting. The company's products also include wireless charging systems for electronic applications. Wisepower's deep relationships with many potential Unidym customers and experience growing electronics businesses fit well with Unidym's leadership in carbon nanotube technology for electronics applications. Wisepower is well-positioned to help Unidym develop manufacturing scale-up and customer acquisition as it moves into the market adoption phase of its business.

"Unidym has built significant value by identifying and developing a large set of market opportunities for carbon nanotube based electronic products," said Christopher Anzalone, Arrowhead's CEO. "Now that Unidym is pushing into the marketplace, Wisepower's resources and market reach will be critical to its ability to grow revenues. The acquisition structure enables Arrowhead to potentially extract substantial value over time as Unidym's technology is adopted on a wider scale and as revenue grows."

Completion of this transaction represents the achievement of an important strategic goal for Arrowhead. The Company has evolved from a diversified nanotechnology company addressing multiple industries to a focused nanomedicine company, and the Unidym sale is the final step in this transition. This enables Arrowhead to allocate its resources toward a single industry, operate and grow in a more cohesive fashion, and it lays the groundwork for Arrowhead to emerge as a leader in the field.

"We are able to further increase our operational efficiencies by building a team of professionals with a single industry focus and by enabling more synergies among our subsidiaries," continued Dr. Anzalone. "This transition is also potentially beneficial to shareholder value from an outward-looking perspective. We now have a far simpler and more cohesive story to articulate to analysts and institutional investors, and I am confident that our value proposition will fit more neatly into investors' established frameworks. The ability to focus our resources, including cash flow from the Unidym sale, on continued investment in our current nanomedicine companies and strengthening our relationships with potential pharma partners should allow us to maximize each subsidiary's success and, therefore, shareholder value."

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the current recessionary environment, capital resources available to us, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.


About Arrowhead Research Corporation
Arrowhead Research Corporation (NASDAQ: ARWR) is a nanotechnology company commercializing new medical technologies. Arrowhead is seeking to build value for shareholders through the progress of its portfolio companies. Currently, Arrowhead is focused primarily on its two majority owned subsidiaries, Calando, at the forefront of clinical application of RNAi delivery technology, and Ablaris, newly formed to commercialize anti-obesity technology. Arrowhead also has minority investments in two privately held nanobiotech companies.

For more information, please click here

Brandi Floberg
The Piacente Group, Inc.

Copyright © Arrowhead Research Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Raman Whispering Gallery Detects Nanoparticles September 1st, 2014

A new, tunable device for spintronics: An international team of scientists including physicist Jairo Sinova from the University of Mainz realises a tunable spin-charge converter made of GaAs August 29th, 2014

Nanoscale assembly line August 29th, 2014

New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014


Raman Whispering Gallery Detects Nanoparticles September 1st, 2014

Nanoscale assembly line August 29th, 2014

New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014

New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014


Nanotech Security Corp. to Acquire Fortress Optical Features Ltd., a Leading Producer of Banknote Security Features August 27th, 2014

Applied Nanotech Holdings, Inc. Expects Approval to Become PEN Inc. : Two Leading Companies Combine to Bring to Market Advanced Products Enabled by Nanotechnology; Shareholder Meeting Will Occur on Friday, August 22, 2014, in Irving, TX to Vote on the Combination August 15th, 2014

Keysight Technologies Begins Operations August 1st, 2014

Bruker Announces Acquisition of High-Speed, 3D Super-Resolution Fluorescence Microscopy Company Vutara July 28th, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE